A novel colorimetric broth microdilution method to determine the minimum inhibitory concentration (MIC) of antibiotics and essential oils against Helicobacter pylori

Pharmazie

Volumn 60, Issue 7, 2005, Pages 498-502

  Weseler, A ^a   Geiss, H K ^a   Saller, R ^b   Reichling, Jürgen ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANISE OIL; ANTIBIOTIC AGENT; CHAMOMILE; ESSENTIAL OIL; FENNEL OIL; LEMON OIL; LEVOFLOXACIN; PEPPERMINT; PLANT EXTRACT; THYME OIL;

ANISE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BASIL; CARAWAY; CARDAMOM; CHEMICAL STRUCTURE; CHRONIC GASTRITIS; COLORIMETRY; CORIANDER; FENNEL; FLOWER; GASTROINTESTINAL DISEASE; GINGER; HELICOBACTER PYLORI; LEMON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ORANGE (FRUIT); ROSEMARY; SPICE; THYME;

ANTI-BACTERIAL AGENTS; COLORIMETRY; CULTURE MEDIA; HELICOBACTER PYLORI; MICROBIAL SENSITIVITY TESTS; OILS, VOLATILE; OXIDOREDUCTASES;

EID: 22644445911     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Bae EA, Han MJ, Kim DH (1999) In vitro Anti-Helicobacter pylori acivity of some flavonoids and their metabolites. Planta Med 65: 442-443.
2. Bamba H, Kondo Y, Wong RM, Semine S, Matsuzaki F (1997) Minimum inhibitory concentration of various single agents and the effect of their combinations against Helicobacter pylori, as estimated by a fast and simple in vitro assay method. Am J Gastroenterol 92: 659-662.
3. Bergonzelli GE, Donnicola D, Porta N, Corthésy-Theulaz IE (2003) Essential oils as components of diat-based approach to management of Helicobacter infection. Antimicrob Agents Chemother 47: 3240-3246.
4. Blaschek W, Ebel S, Hackenthal E, Holzgrabe U, Keller K, Reichling J (2004) Hagers Handbuch der Drogen und Arzneistoffe, HagerROM. Springer Verlag Berlin, Heidelberg, New York.
5. Blaser MJ (1990) Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 161: 626-633.
6. Boyanova L, Derejian S, Koumanova R, Katsarov N, Gergova G, Mitov I, Nikolov R, Krastev, Z (2003) Inhibition of Helicobacter pylori growth in vitro by Bulgarian propolis: preliminary report. J Med Microbiol 52: 417-419.
7. Cellini L, Di Campli E, Fasulli M, Di Bartolomeo S, Allocati N (1996) Inhibition of Helicobacter pylori by garlic extract (Allium sativum). FEMS Immunol Med Microbiol 13: 273-277.
8. Dunn, BE, Cohen H, Blaser M (1997) Helicobacter pylori. Clin Microbiol Rev 10: 720-741.
9. Eidt S, Stolte M, Fischer R (1994) Helicobacter pylori gastritis and primary non-Hodgkin's lymphomas. J Clin Pathol 47: 436-439.
10. Eloff JN (1998) A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Med 64: 711-713.
11. Goodwin CS, Blake P, Blincow E (1986) The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis. J Antimicrob Chemother 17: 309-314.
12. Gribbon LT, Barer MR (1995) Oxidative metabolism in nonculturable Helicobacter pylori and Vibrio vulnificus cells studied by substrate-enhanced tetrazolium reduction and digital image processing. Appl Environ Microbiol 61: 3379-3384.
13. Harkenthal M, Reichling J, Geiss HK, Saller R (1999) Comparative study on the in vitro antibacterial activity of Australian tea tree oil, niaouli oil, manuka oil, kanuka oil, and eucalyptus oil. Pharmazie 54: 460-463.
14. Imai H, Osawa K, Yasuda H, Hamashima H, Arai T, Sasatsu M (2001) Inhibition by the essential oils of peppermint and spearmint of the growth of pathogenic bacteria. Microbios 106 (Suppl 1): 31-39.
15. Irie Y, Tateda K, Matsumoto T, Miyazaki S, Yamaguchi K (1997) Antibiotic MICs and short time-killing against Helicobacter pylori: therapeutic potential of kanamycin. J Antimicrob Chemother 40: 235-240.
16. Kalpoutzaki E, Aligiannis N, Mentis, A, Mitaku S, Charvala C (2001) Composition of essential oil of two Nepeta species and in vitro evaluation of their activity against Helicobacter pylori. Planta Med 67: 880-883.
17. King A (2001) Recommendations for susceptibility tests on fastidious organisms and those requiring sepcial handling. J Antimicrob Chemother 48 (Suppl. I): 77-80.
18. Konstantinopoulou M, Karioti A, Skaltsas S, Skaltsa H (2003) Sesquiterpene lactones from Anthemis altissima and their Anti-Helicobacter pylori activity. J Nat Prod 66: 699-702.
19. Landvatter U (2002) Teebaumöl und Teebaumölformulierungen: Untersuchungen zur Stabilität, Liberation und Permeation durch humane Epidermis sowie zur antimikrobiellen Aktivität unter Berücksichtigung des Keimes Helicobacter pylori. Dissertation University of Heidelberg, Germany.
20. Mabe K, Yamada M, Oguni I, Takahashi T (1999) In vitro and in vivo activities of tea catechins against Helicobacter pylori. Antimicrob Agents and Chemother 43: 1788-1791.
21. Marimon JM, Bujanda L, Gutierrez-Stampa MA, Cosme A, Arenas JL (1998) In vitro bactericidal effect of wine against Helicobacter pylori. Am J Gastroenterol 93: 1392.
22. McNulty CA, Wilson MP, Havinga W, Johnston B, O'Gara EA, Maslin DJ (2001) A pilot study to determine the effectiveness of garlic oil capsules in the treatment of dyspeptic patients with Helicobacter pylori. Helicobacter 6: 249-253.
23. Meletiadis J, Mouton JW, Meis JFGM, Bouman BA, Donelly JP, Verweij PE, Network E (2001) Colorimetric assay for antifungal susceptibility testing of Aspergillus species. J Clin Microbiol 39: 3402-3408.
24. Midolo PD, Lambert JR, Turnidge J (1996) Metronidazole resistance. A predictor of failure of Helicobacter pylori eradication by triple therapy. J Gastroenterol Hepatol 11: 290-292.
25. O'Gara EA, Hill DJ, Maslin DJ (2000) Activities of garlic oil, garlic powder, and their diallyl constituents against Helicobacter pylori. Appl Environ Mocrobiol 66: 2269-2273.
26. Ohno T, Kita M, Yamaoka Y, Imamura S, Yamamoto T, Mitsufuji S, Kodama T, Kashima K, Imanishi J (2003) Antimicrobial acitivity of essential oils against Helicobacter pylori. Helicobacter 8: 207-215.
27. Parsonett J, Friedmann GD, Vandersteen DP, Chang Y, Vogelmann JH, Orentreich N, Sibley RK (1991) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325: 1127-1131.
28. Parsonett J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelmann JH, Friedmann GD (1994) Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330: 1267-1271.
29. Piccolomini R, Di Bonaventura G, Catamo G, Carbone F, Neri M (1997) Comparative evaluation of the E Test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents. J Clin Microbiol 35: 1842-1846.
30. Recklinghausen von G, Maio di C, Ansorg R (1993) Activity of antibiotics and azole antimycotics against Helicobacter pylori. Zbl Bakt 280: 279-285.
31. Reichling J, Harkenthal M, Saller R (1999) In-vitro Untersuchungen zur antimikrobiellen Wirkung ausgewählter ätherischer Öle. Erfahrungsheilkunde 48: 357-366.
32. Roehm NW, Rodgers GH, Hatfield SM, Glasebrook AL (1991) An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium slat XTT. J Immunol Meth 142: 257-265.
33. Roslev P, King GM (1993) Application of a tetrazolium salt with a water-soluble formazan as an indicator of viability in respiring bacteria. Appl Environ Microbiol 59: 2891-2896.
34. Takahashi Y, Masuda N, Otsuki M, Miki M, Nishino T (1997) In vitro activity of HSR-903, a new quinolone. Antimicrob Agents Chemother 41: 1326-1330.
35. Teuscher E, Bauermann U, Werner M (2002) Gewürzdrogen. Wissenschaftliche Verlagsgesellschaft, Stuttgart
36. Thorn SM, Horobin RW, Seidler E, Barer MR (1993) Factors affecting the selection and use of tetrazolium salts as cytochemical indicators of microbial viability and activity. J Appl Bacteriol 74: 433-443.
37. Tzakou O, Skaltsa H (2003) Composition and antibacterial activity of the essential oil Satureja parnassica subsp. parnassica. Planta Med 69: 282-284.
38. Versalovic J, Shortridge D, Kibler K (1999) Mutations in 23 S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrobial Agent Chemother 43: 1788-1791.
39. Warren J, Marshall B (1983) Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 4: 1273-1275.
40. Weseler A, Geiss HK, Saller R, Reichling J (2002a) Antifungal effects of Australian tea tree oil on Malassezia pachydermatis isolated from canines suffering from cutaneous skin disease. Schweiz Arch Tierheilk 144: 215-221.
41. Weseler A, Saller R, J Reichling (2002b) Comparative investigation of the antimicrobial activity of PADMA 28 and selected European herbal drugs. Forsch Komplementärmed Klass Naturheilk 9: 346-351.